Physician profile
Natalie N Stapleton
NPI 1497183644
$11,215.91
in general payments reported to CMS, 2019-2025
13 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,338 · 2022: $3,036 · 2023: $3,509 · 2024: $58.68 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,860 · Travel and Lodging: $1,409 · Food and Beverage: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,860.00 |
| Travel and Lodging | $1,409.28 |
| Food and Beverage | $572.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $7,341.56 | 2021-2023 | |
| Abbott Laboratories | $1,731.72 | 2021-2022 | |
| Medtronic, INC. | $868.95 | 2021-2022 | |
| Nevro Corp. | $734.45 | 2022-2023 | Senza |
| Globus Medical, INC. | $235.65 | 2024-2025 | Senza, Excelsius3d Imaging System, Attrax |
| Relievant Medsystems, INC. | $116.30 | 2021 | |
| Depuy Synthes Sales INC. | $81.26 | 2025 | Expedium |
| Smith+Nephew, INC. | $20.70 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.16 | 2021 | |
| Zimmer Biomet Holdings, INC. | $18.61 | 2021 | |
| Arbor Pharmaceuticals, INC. | $16.50 | 2021 | |
| Innovation Technologies INC | $16.19 | 2025 | Irrisept |
| Baxter Healthcare | $14.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Stapleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.